Juan Torres-Martin
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical Characteristics and Trends of Lymphogranuloma Venereum Versus Non-LGV Chlamydia trachomatis Anorectal Infections: A Six-Year Retrospective Study.
Journal: Sexually transmitted diseases
Published: March 24, 2026
Effectiveness of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in people with HIV with very high viral load (≥500 000 copies/mL).
Journal: The Journal of antimicrobial chemotherapy
Published: March 04, 2026
Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.
Journal: AIDS (London, England)
Published: July 02, 2025
Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.
Journal: AIDS (London, England)
Published: July 02, 2025
Impact of antiretroviral regimens containing integrase inhibitors on achieving viral suppression at ultra-low levels compared to other antiretroviral therapy strategies.
Journal: AIDS (London, England)
Published: June 11, 2025
Triglyceride-glucose index and FIB-4 score in relation to cardiovascular disease risk among people with HIV: a retrospective cohort study.
Journal: Frontiers in medicine
Published: May 30, 2025
Bartonella spp. infection in a person with HIV and advanced immunosuppression: A case report.
Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: October 18, 2024
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Journal: The Journal of antimicrobial chemotherapy
Published: July 25, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026